Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans

Strengthens Kyowa Kirin’s commitment to expanding access to medicines Reinforces investment in U.S. manufacturing and innovation TOKYO and PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, today announced a voluntary agreement with the U.S. government to improve access and lower the cost […]